Surgeons are already using robotic technology in the hospitals and seeing better outcomes because their procedures are more precise. The robotic technology can bring strategic value to knee replacement surgery, but the technology can be a huge capital expenditure for ASCs.
When would it make sense to invest? Is it financially viable for ASCs?
Jess Lonner, MD, an orthopedic surgeon at Rothman Institute, will speak about his experience with robotic technology in the ASC in a webinar on Thursday, July 2. Dr. Lonner will talk about the clinical benefits he sees with robotic technology and how an orthopedics robotic program can be financially viable for ASCs.
There will also be a discussion about the new technology that improves patient outcomes and market presence.
To learn more and register for the webinar, click here.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.